Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, et al. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Siegel JD, Rhinehart E, Jackson M, Chiarello L, HICPAC. Bacteremia due to vancomycin-dependent Enterococcus faecium.

2017 Jun;51(6):496-503. doi: 10.1177/1060028017692357. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients. eCollection 2020.Şimşek-Yavuz S, Akar AR, Aydoğdu S, Berzeg-Deniz D, Demir H, Hazırolan T, Özatik MA, Özer N, Sargın M, Topcuoğlu EN, Turhan N, Yılmaz MB, Azap Ö, Başaran S, Çağ Y, Çağatay A, Çınar G, Doğan-Kaya S, Hızmalı L, Işık ME, Kılıçaslan N, Menekşe Ş, Meriç-Koç M, Öztürk S, Şensoy A, Tezer-Tekçe Y, Tükenmez-Tigen E, Uygun-Kızmaz Y, Velioğlu-Öcalmaz MŞ, Yeşilkaya A, Yılmaz E, Yılmaz N, Yılmaz-Karadağ F.Turk Gogus Kalp Damar Cerrahisi Derg.

2020;25(6):547-551. doi: 10.5863/1551-6776-25.6.547.Ramos-Martínez A, Pericàs JM, Fernández-Cruz A, Muñoz P, Valerio M, Kestler M, Montejo M, Fariñas MC, Sousa D, Domínguez F, Ojeda-Burgos G, Plata A, Vidal L, Miró JM; Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES).PLoS One. The general use today. 2013 Sep;57(5):767. doi: 10.1093/cid/cit338. Ampicillin systemic 500 mg (MYLAN 116 MYLAN 116) Regional dissemination of vancomycin-resistant enterococci resulting from interfacility transfer of colonized patients. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Britt NS, Potter EM, Patel N, Steed ME. 2015;10(7):1215-40. doi: 10.2217/fmb.15.46. Use: For the treatment of soft tissue infections. Poutsiaka DD, Skiffington S, Miller KB, et al. Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States. 2019 Dec 27;8(6):571-573. doi: 10.1093/jpids/piz028.Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, Nadel S, Schlapbach LJ, Tasker RC, Argent AC, Brierley J, Carcillo J, Carrol ED, Carroll CL, Cheifetz IM, Choong K, Cies JJ, Cruz AT, De Luca D, Deep A, Faust SN, De Oliveira CF, Hall MW, Ishimine P, Javouhey E, Joosten KFM, Joshi P, Karam O, Kneyber MCJ, Lemson J, MacLaren G, Mehta NM, Møller MH, Newth CJL, Nguyen TC, Nishisaki A, Nunnally ME, Parker MM, Paul RM, Randolph AG, Ranjit S, Romer LH, Scott HF, Tume LN, Verger JT, Williams EA, Wolf J, Wong HR, Zimmerman JJ, Kissoon N, Tissieres P.Intensive Care Med. Gonorrhea. Impact of a series of interventions in vancomycin prescribing on use and prevalence of vancomycin-resistant enterococci. Beezhold DW, Slaughter S, Hayden MK, et al. All rights reserved. Gonzales RD, Schreckenberger PC, Graham MB, et al. Management of infections due to resistant enterococci: a review of therapeutic options. COVID-19 is an emerging, rapidly evolving situation. Hindler JA, Wong-Beringer A, Charlton CL, Miller SA, Kelesidis T, Carvalho M, et al. Plosker GL, Figgitt DP. Clipboard, Search History, and several other advanced features are temporarily unavailable. Edmond MB, Ober JF, Weinbaum DL, et al. Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings 2007. Shay DK, Maloney SA, Montecalvo M, et al. Intervention to reduce transmission of resistant bacteria in intensive care.

2013 Sep;57(5):768-70. doi: 10.1093/cid/cit331. Free PMC article 2015 Oct 1;61(7):1125-6. doi: 10.1093/cid/civ466. Montecalvo MA, Shay DK, Gedris C, et al. An analysis of 110 serious enterococcal infections. Diversity among multidrug-resistant enterococci. Role of enterococcus in intraabdominal sepsis.